Sign in

    Chi Fong • Bank of America

    Chi Fong is an analyst at Bank of America, but based on the available public records and search results as of August 2025, there is no verified information confirming their exact title, specific company coverage, performance metrics, or detailed career timeline. There is no evidence of a LinkedIn profile for Chi Fong connected to Bank of America, and no information about professional credentials or past experience at other firms. As a result, a comprehensive professional profile cannot be provided at this time due to lack of verifiable data.

    Chi Fong's questions to Galapagos NV (GLPG) leadership

    Chi Fong's questions to Galapagos NV (GLPG) leadership • Q1 2025

    Question

    Chi Fong, on for Jason Gerberry, asked for the company's view on Parkinsonism as a class effect for BCMA-targeted therapies, the mitigation strategies used for GLPG5301, and whether any cases have been seen since the study resumed.

    Answer

    Clinical Program Head Omotayo Fasan stated that their mitigation strategy involves managing known risk factors like high tumor volume and rapidly rising lymphocyte counts. She confirmed that since restarting the study with these protocol amendments, they have been able to manage all enrolled patients and have not observed any further occurrences of Parkinsonism.

    Ask Fintool Equity Research AI